Keryx Biopharmaceuticals

Revision as of 12:55, 5 May 2010 by Mike (talk | contribs) (SW: →‎Related Sourcewatch: *[[)

(diff) ←Older revision | Latest revision (diff) | Newer revision→ (diff)

Keryx Biopharmaceuticals "s focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease." ^[1]

Ron Bentsur - Chief Executive Officer
James F. Oliviero - Chief Financial Officer

Contents

Board

Accessed May 2010: ^[2]

Contact

URL: http://www.keryx.com/page.cfm?hmid=&smid=&pg=main

Resources and articles

Related Sourcewatch

References

↑ About, Keryx Biopharmaceuticals, accessed May 5, 2010.
↑ Directors, Keryx Biopharmaceuticals, accessed May 5, 2010.

Retrieved from "https://www.sourcewatch.org/index.php?title=Keryx_Biopharmaceuticals&oldid=474927"